Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Valeant

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Valeant's Japan sales performance.

valeant

AZ licenses inflammatory bowel disease drug to Allergan for $1.52bn

AZ licenses inflammatory bowel disease drug to Allergan for $1.52bn of psoriasis drug brodalumab to Valeant.

Deal Watch August 2016

Deal Watch August 2016 Finally it was interesting to see that Pharming has recovered from Valeant the North American rights to its product Ruconest. ... Pharming did well to get the rights back especially as it resulted in Valeant having to make a $199m write down of its

Allergan CEO takes issue with 'predatory' price increases

Allergan CEO takes issue with 'predatory' price increases Meanwhile other companies - including Valeant, Turing Pharma and Horizon Pharma - have also been criticised in recent months for implementing massive price increases for old brands.

LEO Pharma picks up AZ skin disease drugs in $1bn deal

LEO Pharma picks up AZ skin disease drugs in $1bn deal AZ has also agreed to transfer European rights to brodalumab, its psoriasis and psoriatic arthritis candidate, from Valeant to LEO Pharma. ... Now, LEO Pharma will focus on bringing the IL-17 receptor monoclonal antibody to market in Europe while Valeant

AstraZeneca sells rights to seven anaesthetics in $770m deal

AstraZeneca sells rights to seven anaesthetics in $770m deal Valeant. ProStraken obtained the European rights to AZ's opioid-induced constipation treatment Moventig (naloxegol), and the firm sold Entocort (budesonide), its inflammatory bowel disease therapy, to Tillotts Pharma.

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics